Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Radient Technologies Inc RDDTF


Primary Symbol: V.RTI.H

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble... see more

TSXV:RTI.H - Post Discussion

View:
Post by City1234 on Dec 21, 2019 8:33pm

New Year

Cam is out and while I still strongly believe that Aurora will "hopefully" pull out of this firepit everyone seems to think they are in. This has not been a good year for them and I would like to see RTI distance themselved with some great partnerships.

With the new year approaching the estimates they provided are even more important....oh and a news release in the next few weeks stating the completion of Edmonton 2 is a must.



Fiscal Q3 2020 (ending December 31, 2019): Radient expects to report revenues of between CAD $10.0 million – CAD $12.0 million.
Fiscal Q4 2020 (ending March 31, 2020): Radient expects to report revenues of between CAD $12.0 million - CAD $14.0 million.

This guidance is based on extraction operations at the Company’s Edmonton I facility during its fiscal Q3 2020 and fiscal Q4 2020 periods only, and does not account for the Company’s entire CAD $25.0 million of cannabis inventory. Throughput capacity at this facility is expected to be 56,000 kg per year of cannabis.

Significant progress was made on the retrofit of Edmonton II, a dedicated hemp extraction line with an expected throughput capacity of 420,000 kg/ year, with completion of construction on track for the end of calendar 2019. Additional commissioning and validation work is expected to commence in early calendar 2020, after licensing is granted by Health Canada
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities